Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma by O. Abidi et al.
Mutational analysis of the RB1 gene in Moroccan patients
with retinoblastoma
Submitted by Guy Lenaers on Tue, 04/07/2015 - 15:01
Titre Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma
Type de
publication Article de revue
Auteur
Abidi, Omar [1], Knari, Sara [2], Sefri, Hajar [3], Charif, Majida [4], Senechal,
Audrey [5], Hamel, Christian [6], Rouba, Hassan [7], Zaghloul, Khalid [8], Kettani,
Asmaa El [9], Lenaers, Guy [10], Barakat, Abdelhamid [11]
Pays Etats-Unis
Editeur Molecular Vision










Child, Preschool [12], Codon, Nonsense [13], DNA Mutational Analysis [14], Exons
[15], Female [16], Frameshift Mutation [17], Genetic Association Studies [18],
Genotype [19], Germ-Line Mutation [20], Heterozygote [21], Homozygote [22],
Humans [23], Infant [24], Introns [25], Male [26], Morocco [27], Pedigree [28],
Phenotype [29], Polymerase Chain Reaction [30], Retina [31], Retinal Neoplasms
[32], Retinoblastoma [33], Retinoblastoma Protein [34]
Résumé en
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PURPOSE: Retinoblastoma (RB), the most common intraocular tumor occurring
in infancy and early childhood, is most often related to mutations in the RB1 gene.
In this study, we screened the RB1 germline mutations in 41 unrelated Moroccan
patients with retinoblastoma, 25 heritable cases, and 16 sporadic unilateral cases.
METHODS: After complete ophthalmic examinations were performed and consent
obtained, DNA was extracted from peripheral blood, and screening of RB1
mutations was performed with PCR direct sequencing of the promoter and the 27
coding exons of the RB1 gene.
RESULTS: We identified ten germline mutations in 10/41 (24.39%) unrelated
patients, among which three had not been previously reported. The mutation
detection rate was 40% (10/25) in the heritable cases and 0% (0/16) in the
sporadic unilateral cases. Of these mutations, six were nonsense, and three were
frameshifts, all associated with severe phenotypes resulting in bilateral and
multifocal tumors. One splice site mutation was found in a familial case associated
with a low expressivity phenotype resulting in unilateral and unifocal tumors.
Moreover, eight intronic variants were identified, three of which were novel.
CONCLUSIONS: This first report of RB1 gene screening in Moroccan patients
with retinoblastoma shows a comparable mutational spectrum to those reported
previously, which has evident importance for managing patients with
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